Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation – Oncology Nurse Advisor
Oncology Nurse Advisor |
Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
Oncology Nurse Advisor Patients with endothelial activation prior to lymphodepletion chemotherapy are at greater risk of experiencing neurologic adverse events (AEs) after being treated with chimeric antigen receptor (CAR) T-cell therapy. Although the development of CAR T … |
